Open-label study to assess the safety, pharmacokinetics and pharmacodynamics of five oral insulin formulations in healthy subjects

Trial Profile

Open-label study to assess the safety, pharmacokinetics and pharmacodynamics of five oral insulin formulations in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 26 May 2010

At a glance

  • Drugs Insulin (Primary)
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 26 May 2010 Results have been published in the journal Diabetes, Obesity and Metabolism, according to a Oramed Pharmaceuticals media release.
    • 18 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top